Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Age at menarche and adverse pregnancy and perinatal outcomes: triangulating evidence from multivariable and Mendelian randomization analyses.

International journal of epidemiology·2026
Same author

Effect of a Personalized Mobile App on Glucose Control in Adults With Prediabetes and Type 2 Diabetes: Exploratory Pilot Randomized Controlled Trial.

JMIR human factors·2026
Same author

Structural Cardiac Abnormalities, Ventricular Dysfunction Phenotypes, and Heart Failure Risk among Antiretroviral Therapy-treated People Living with HIV in South Africa.

medRxiv : the preprint server for health sciences·2026
Same author

Associations of stable psychological traits with multi-omic subtypes of Alzheimer's dementia.

Translational psychiatry·2026
Same author

Retinal Vascular Caliber: 6 to 12 Months and 15 to 25 Years Following Hypertensive Pregnancy.

Hypertension (Dallas, Tex. : 1979)·2026
Same author

Prevalence and Correlates of Steatotic Liver Disease Among People With HIV in Uganda.

Open forum infectious diseases·2026
Same journal

A Bundle to Frame Guidelines and American Heart Association Statements.

Circulation·2026
Same journal

<i>Circulation</i> Editors and Editorial Board.

Circulation·2026
Same journal

A New <i>Circulation</i>, For You.

Circulation·2026
Same journal

Cardiovascular Risk Reduction With GLP-1 RA Drugs.

Circulation·2026
Same journal

Obesity, Severe Obesity, and Abdominal Obesity in US Youth and Adults From 1999 to 2023.

Circulation·2026
Same journal

Lipid Profile Testing and Interpretation.

Circulation·2026
See all related articles

Related Experiment Video

Updated: Jun 23, 2026

Multimodal Study of Murine Cardiovascular Remodeling: Four-Dimensional Ultrasound and Mass Spectrometry Imaging
09:43

Multimodal Study of Murine Cardiovascular Remodeling: Four-Dimensional Ultrasound and Mass Spectrometry Imaging

Published on: January 10, 2025

Contrastive Machine Learning to Quantify Hypertensive Multiorgan Damage and Identify New Disease Phenotypes: A

Mohanad Alkhodari1,2, Winok Lapidaire1, Turkay Kart1

  • 1Cardiovascular Clinical Research Facility (CCRF), Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, United Kingdom (M.A., W.L., T.K., Z.X., S.K., A.F., S.B., N.S., K.S., A.J.L., P.L.).

Circulation
|June 21, 2026
PubMed
Summary
This summary is machine-generated.

A new machine learning model, HyperScore, accurately quantifies multiorgan damage from hypertension, outperforming blood pressure alone in predicting outcomes. It identifies distinct disease phenotypes, paving the way for personalized hypertension management.

Keywords:
contrastive machine learninghypertensionorgan damageprogression trajectorypseudotemporal modeling

Related Experiment Videos

Last Updated: Jun 23, 2026

Multimodal Study of Murine Cardiovascular Remodeling: Four-Dimensional Ultrasound and Mass Spectrometry Imaging
09:43

Multimodal Study of Murine Cardiovascular Remodeling: Four-Dimensional Ultrasound and Mass Spectrometry Imaging

Published on: January 10, 2025

Area of Science:

  • Cardiovascular Medicine
  • Medical Imaging
  • Machine Learning

Background:

  • Hypertension causes significant organ damage, increasing vascular event and mortality risk.
  • Subclinical organ damage is a key predictor but challenging to detect clinically.
  • Novel methods are needed to quantify and track hypertension-induced multiorgan damage.

Purpose of the Study:

  • To develop a machine learning framework for quantifying multiorgan damage in hypertension.
  • To map disease progression and predict organ-specific trajectories.
  • To identify distinct hypertension-associated organ damage phenotypes.

Main Methods:

  • Utilized a semisupervised contrastive trajectory inference (cTI) framework on UK Biobank data (27,099 participants).
  • Analyzed 566 multimodal imaging and nonimaging variables across multiple organs (heart, brain, kidneys, etc.).
  • Validated externally using the Atherosclerosis Risk in Communities (ARIC) study (5,507 participants).

Main Results:

  • Developed HyperScore, a global organ damage score with AUC of 0.964 for severe disease identification in UK Biobank.
  • HyperScore stages significantly predicted survival, outperforming blood pressure stratification.
  • Identified 6 distinct hypertensive disease phenotypes (HyperTrajectory) with external validation in ARIC.

Conclusions:

  • Machine learning-derived organ damage scores are feasible for assessing hypertension.
  • HyperScore enables identification of distinct hypertension-associated organ damage phenotypes.
  • Potential for personalized risk assessment and phenotype-specific interventions using imaging data.